United States · FDA National Drug Code directory
Cefpodoxime Proxetil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-140_95331369-8343-4244-8d82-03a1bc4af0c0
- Product NDC
- 65862-140
- Form
- GRANULE, FOR SUSPENSION
- Composition / generic term
- Cefpodoxime Proxetil
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070608
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFPODOXIME PROXETIL — 50 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (65862-140-01) / 100 mL in 1 BOTTLE · 65862-140-01
- 1 BOTTLE in 1 CARTON (65862-140-50) / 50 mL in 1 BOTTLE · 65862-140-50
- 1 BOTTLE in 1 CARTON (65862-140-75) / 75 mL in 1 BOTTLE · 65862-140-75
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →